𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of esorubicin in advanced renal carcinoma

✍ Scribed by Hurteloup, P.; Chollet, P.; Roche, H.; Chevallier, B.; Cappelaere, P.; Van Glabbeke, M.; Hayat, M.; Armand, J.P.

Book ID
122887465
Publisher
Elsevier Science
Year
1989
Weight
174 KB
Volume
25
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of Didemnin B in patients
Phase II trial of Didemnin B in patients with advanced renal cell carcinoma
✍ Robert Motzer; Howard Scher; Dean Bajorin; Cora Sternberg; George J. Bosl πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 115 KB

Twenty-three patients with advanced renal cell cancer were treated with Didemnin B. One partial response was achieved (5070) in 21 evaluable patients. An allergic reaction was noted in four patients including one patient with anaphylaxis. Didemnin B is not recommended in the treatment of renal cell